Stimoxygen
Stimoxygen is a startup headquartered in Belfast, United Kingdom, founded in 2021. It has won about £760k in competitive Innovate UK grants since 2023, according to UK Research and Innovation.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Innovation grants
Stimoxygen has won about £760k in competitive Innovate UK grants since 2023.
- StimOxyGen: Oxygen-generating nanoparticles to enhance efficacy of radiotherapy and immunotherapy for pancreatic cancer (£607k, 2025)
- StimOxyGen: Oxygen-generating nanoparticles to enhance the anti-tumour immune response (£153k, 2024)
R&D ecosystem
Stimoxygen sits inside the Belfast R&D ecosystem in the Global R&D Labs Directory.
Other startups in Belfast
Related
- Innovation profile of Belfast
- United Kingdom: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does Stimoxygen do?
Stimoxygen works in medical devices. Its Innovate UK projects include: StimOxyGen: Oxygen-generating nanoparticles to enhance efficacy of radiotherapy and immunotherapy for pancreatic cancer.
Where is Stimoxygen based?
Stimoxygen is headquartered in Belfast, United Kingdom.
When was Stimoxygen founded?
Stimoxygen was founded in 2021.
Source records: Companies House and UK Research and Innovation.
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.